User menu

FXI concentrate use and risk of thrombosis

Bibliographic reference Bolton-Maggs, P. ; Goudemand, J. ; Hermans, Cédric ; Makris, M. ; de Moerloose, P.. FXI concentrate use and risk of thrombosis. In: Haemophilia, Vol. 20, no. 4, p. e349-e351 (2014)
Permanent URL
  1. Bolton-Maggs P. H. B., Factor XI deficiency--resolving the enigma?, 10.1182/asheducation-2009.1.97
  2. PEYVANDI F., DI MICHELE D., BOLTON-MAGGS P. H. B., LEE C. A., TRIPODI A., SRIVASTAVA A., , Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity : Classification of rare bleeding disorders, 10.1111/j.1538-7836.2012.04844.x
  3. RUGERI L., QUÉLIN F., CHATARD B., DE MAZANCOURT P., NEGRIER C., DARGAUD Y., Thrombin generation in patients with factor XI deficiency and clinical bleeding risk : THROMBIN GENERATION IN FXI DEFICIENCY, 10.1111/j.1365-2516.2010.02246.x
  4. Guéguen Paul, Galinat Hubert, Blouch Marie-Thérèse, Bridey Françoise, Duchemin Jérôme, Le Gal Grégoire, Abgrall Jean-François, Pan-Petesch Brigitte, Biological determinants of bleeding in patients with heterozygous factor XI deficiency : Factor XI Deficiency and Bleeding Determinants, 10.1111/j.1365-2141.2011.08945.x
  5. Bolton-Maggs P.H.B, Colvin B.T, Satchi G, Lee C.A, Lucas G.S, Thrombogenic potential of factor XI concentrate, 10.1016/s0140-6736(94)92237-3
  6. Mannucci, Blood, 84, 1314 (1994)
  7. Bolton-Maggs P. H. B., Perry D. J., Chalmers E. A., Parapia L. A., Wilde J. T., Williams M. D., Collins P. W., Kitchen S., Dolan G., Mumford A. D., The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation, 10.1111/j.1365-2516.2004.00944.x
  8. Livnat, Thromb Haemost, 102, 487 (2009)
  9. O'CONNELL N. M., RIDDELL A. F., PASCOE G., PERRY D. J., LEE C. A., Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency, 10.1111/j.1365-2516.2008.01663.x
  10. Roemisch JR Identification of activated FXI as the major biochemical root cause in IVIG batches associated with thromboembolic events http://webmedcentralcom/article_view/2002